Hoth Therapeutics, Inc. (HOTH) NASDAQ

1.90

-0.38(-16.67%)

Updated at January 08 04:00PM

Currency In USD

Valuation

Market Cap4.91M
Enterprise Value-4.33M
P/E Ratio-1.75
PEG Ratio-0.1
Price/Sales Ratio220.32
Price/Book Ratio1.75
Enterprise/Revenue86.13
Enterprise/EBITDA-0.94

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-126.1
Operating Margin-126.48

Management Effectiveness

Return On Assets-0.9
Return On Equity-0.9

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-153,149
Net Income-7.85M
Diluted EPS-2.3

Balance Sheet

Total Cash8.02M
Total Cash/Share1.16
Total Debt33,807
Total Debt/Equity0
Current Ratio10.16
Book Value Per Share1.09

Price History

52-Week Change40.74
52-Week High3.8
52-Week Low0.58
Moving Average 50 Days0.86
Moving Average 200 Days0.96

Statistics

Average Volume7.99M
Shares Outstanding6.9M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateOctober 26, 2022